REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Farmaceutico Lamosan C.L. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Dental Laboratories
Full name: Laboratorio Farmaceutico Lamosan C.L. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Laboratorio Farmaceutico Lamosan C.L. is an enterprise in Ecuador, with the main office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on September 24, 1973. 104 (2021) employees currently work for Laboratorio Farmaceutico Lamosan C.L.. In 2022, the company reported a net sales revenue increase of 16%. During that time, Laboratorio Farmaceutico Lamosan C.L.’s total assets grew by 6.26%. In, 2022, the company’s net profit margin increased by 0.25%.

Headquarters
Paseo del Sol S6-574, Planta Industrial Bldg. , Floor 1
Quito; Pichincha;

Contact Details: Purchase the Laboratorio Farmaceutico Lamosan C.L. report to view the information.

Website: http://www.lamosan.com

Basic Information
Total Employees:
Purchase the Laboratorio Farmaceutico Lamosan C.L. report to view the information.
Outstanding Shares:
Purchase the Laboratorio Farmaceutico Lamosan C.L. report to view the information.
Registered Capital:
Purchase the Laboratorio Farmaceutico Lamosan C.L. report to view the information.
Incorporation Date:
September 24, 1973
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Laboratorio Farmaceutico Lamosan C.L. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
16%
Total operating revenue
15.33%
Operating profit (EBIT)
96.67%
EBITDA
52.08%
Net Profit (Loss) for the Period
74.92%
Total assets
6.26%
Total equity
-3.42%
Operating Profit Margin (ROS)
3.56%
Net Profit Margin
0.25%
Return on Equity (ROE)
0.88%
Debt to Equity Ratio
3.2%
Quick Ratio
-0.02%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?